Medindia

X

Global Med Technologies(R) Welcomes Pennsylvania Hospital Group as New Client

Wednesday, December 16, 2009 Press Release J E 4
Advertisement


DENVER, Dec. 15 Global Med Technologies®, Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international healthcare information technology company, today announced that its Wyndgate Technologies® division has licensed its SafeTrace Tx® transfusion management software to Jameson Health System ("Jameson") of New Castle, Pennsylvania. Jameson will also be using the services of PeopleMed®, Inc. for validation and Hemo-Net® for remote hosting. Terms of the agreement were not disclosed.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

Global Med's SafeTrace Tx is a leading transfusion management software solution for transfusion services and hospital blood banks. It will provide Jameson with comprehensive tracking of orders, specimens, blood products, derivatives, and accessories, with a complete testing and transfusion history in one consolidated record. SafeTrace Tx will help guide blood bank technicians in selecting, crossmatching and issuing appropriate blood products for their patients as well as helping to reduce waste and increase efficiency. SafeTrace Tx has patented features which also allow hospitals to effectively share patient data and work more efficiently within a multi-facility system.

Wm. Scott Dustin, Global Med's Senior Vice President of Sales and Marketing, the Americas, commented, "Global Med has been an industry leader in the blood banking industry for over a decade. The Company now provides comprehensive business solutions for our clients. We are pleased to be able to assist Jameson Health System with a robust transfusion management system and additional services to get them operational quickly. Global Med's newly acquired Hemo-Net division will provide cost-saving remote hosting for their software, while our PeopleMed subsidiary will assist Jameson's staff with the system validation for a more rapid implementation."

About Jameson Health System

Jameson Health System operates two campuses, Jameson North and Jameson South, a 308 bed facility. Jameson is committed to providing convenient, affordable, high quality healthcare to the community. The organization has primary care services, three community health centers, acute inpatient and outpatient services and post acute care services. Jameson Hospital, the primary subsidiary of Jameson Health System, Inc., continues to be a healthcare leader and the largest employer in Lawrence County, Pennsylvania.

About Global Med Technologies®, Inc.

Global Med Technologies, Inc. is an international healthcare information technology company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med's products are deployed in 20 countries and serve over 2,100 transfusion centers, blood banks and laboratory sites.

Global Med's domestic companies are Wyndgate Technologies®, a leader in software products and services for donor centers and hospital transfusion services; eDonor®, which offers web-based donor relationship management systems; Hemo-Net®, a healthcare application service provider; and PeopleMed®, Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.

Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.

For more information about Global Med's products and services, please call 800-996-3428 or visit www.globalmedtech.com.

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.

SOURCE Global Med Technologies, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
CalciMedica Achieves Milestone and Draws Down Seco...
S
American Lung Association Offers Seven Tips to Qui...